Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
201.87
-0.22 (-0.11%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Charles River Laboratories Intl
< Previous
1
2
3
4
5
6
7
8
9
Next >
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 13, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Charles River Laboratories Announces Second-Quarter 2024 Results
August 07, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
July 30, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
July 24, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
July 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River to Perform Plasmid Manufacturing for AAVantgarde
July 08, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
June 25, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
June 17, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
June 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
June 06, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
June 04, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at William Blair and Jefferies Conferences
June 03, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
May 30, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces First-Quarter 2024 Results
May 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
May 02, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
April 22, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
April 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
April 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
April 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
April 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River to Perform Plasmid Production for Ship of Theseus
April 04, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
April 01, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
March 27, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
March 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
March 14, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
February 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
February 20, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
January 29, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.